Traders should monitor CTSO's stock price closely for signs of sustained recovery above $1.00; a reverse stock split announcement could trigger short-term volatility. Delisting would severely impact liquidity and likely lead to a significant price decline. Consider hedging or reducing exposure if the stock fails to show consistent strength in the coming months.
Price Chart
Executive Summary
Cytosorbents Corp (CTSO) received a 180-day extension from Nasdaq, until September 28, 2026, to regain compliance with the $1.00 minimum bid price requirement after failing to meet it for 30 consecutive days. The company may implement a reverse stock split to address the deficiency, but there is no assurance it will avoid delisting.
Key Facts
- Nasdaq granted Cytosorbents a 180-day extension (until September 28, 2026) to regain compliance with the $1.00 minimum bid price rule (Nasdaq Listing Rule 5550(a)(2))
- The company was initially notified of non-compliance on October 2, 2025, and had until March 31, 2026, to regain compliance, which it failed to do
- To regain compliance, CTSO's stock must close at or above $1.00 for 10 consecutive trading days before the new deadline
- The company is considering a reverse stock split as a potential remedy
- The stock remains listed on Nasdaq during the extension period, but delisting remains a risk if compliance is not achieved
Financial Impact
High risk of delisting if stock price does not sustain above $1.00 for 10 consecutive days by September 28, 2026; potential reverse stock split could lead to shareholder dilution and reduced liquidity
Risk Factors
- Risk of delisting if the stock fails to close above $1.00 for 10 consecutive days by September 28, 2026
- Potential shareholder dilution and reduced trading volume if a reverse stock split is implemented
- Loss of institutional investor base and reduced market liquidity upon delisting
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-038859 |
| Document: 0001104659-26-038859-index-headers.html | 0001104659-26-038859 |
| Document: 0001104659-26-038859-index.html | 0001104659-26-038859 |
| Document: 0001104659-26-038859.txt | 0001104659-26-038859 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 23, 2026 4w ago | 8-K | $4.91 $5.35 | ▲ +8.96% | ▲ +8.27% | $4.85 (−1.22%) |
Aug 6, 2026 11w ago | Press Release | $0.3600 $0.3501 | ▲ +2.75% | ▲ +2.35% | $4.85 (−1247.22%) |
Jun 25, 2026 17w ago | DEFA14A | $0.3620 $0.3600 | ▼ −0.55% | ▼ −1.94% | $4.85 (+1239.78%) |
Jun 16, 2026 19w ago | Insider Cluster | $0.5189 $0.3694 | ▼ −28.81% | ▼ −28.86% | $4.85 (+834.67%) |
Apr 15, 2026 27w ago | 10-K/A | $0.6100 $0.5710 | ▼ −6.39% | ▼ −12.21% | $4.85 (+695.08%) |
Apr 2, 2026 29w ago | 8-K | $0.5830 $0.6100 | ▼ −4.63% | ▲ +5.25% | $4.85 (−731.90%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers